Region‐specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin

Purpose:  It is commonly assumed that antiepileptic drugs (AEDs) act similarly in the various parts of the brain as long as their molecular targets are present. A few experimental studies on metabolic effects of vigabatrin, levetiracetam, valproate, and lamotrigine have shown that these drugs may act differently in different brain regions. We examined effects of chronic treatment with levetiracetam or phenytoin on mRNA levels to detect regional drug effects in a broad, nonbiased manner.

[1]  C. Harley,et al.  Locus Ceruleus Activation Initiates Delayed Synaptic Potentiation of Perforant Path Input to the Dentate Gyrus in Awake Rats: A Novel β-Adrenergic- and Protein Synthesis-Dependent Mammalian Plasticity Mechanism , 2004, The Journal of Neuroscience.

[2]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[3]  G. Krauss,et al.  Similarities in Mechanisms and Treatments for Epileptic and Nonepileptic Myoclonus , 2003, Epilepsy currents.

[4]  H. Klitgaard,et al.  Is the persistent sodium current a specific target of anti-absence drugs? , 2004, Neuroreport.

[5]  P. Worley,et al.  Site of anticonvulsant action on sodium channels: autoradiographic and electrophysiological studies in rat brain. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Vanninen,et al.  Clinical picture of EPM1‐Unverricht‐Lundborg disease , 2008, Epilepsia.

[7]  W. Löscher,et al.  Differential effects of vigabatrin, γ-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  Anne Sabers,et al.  Effect of Antiepileptic Drugs on Cognitive Function in Individuals with Epilepsy , 2012, Drugs.

[9]  E. Aronica,et al.  Region-Specific Overexpression of P-glycoprotein at the Blood-Brain Barrier Affects Brain Uptake of Phenytoin in Epileptic Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[10]  B. Lynch,et al.  Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. , 2003, European journal of pharmacology.

[11]  K. Nocka,et al.  The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Bernardi,et al.  Levetiracetam does not modulate neuronal voltage-gated Na + and T-type Ca 2+ currents , 2001, Seizure.

[13]  L. Gjerstad,et al.  Up‐regulation of hippocampal glutamate transport during chronic treatment with sodium valproate , 2001, Journal of neurochemistry.

[14]  A. Triller,et al.  The inhibitory neuronal glycine receptor , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  W. Löscher,et al.  Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats , 2004, Epilepsy Research.

[16]  W. Löscher,et al.  The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata , 1996, Brain Research.

[17]  L. Gjerstad,et al.  Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels , 2001, Epilepsy Research.

[18]  A. Marson,et al.  Carbamazepine versus phenytoin monotherapy for epilepsy. , 2002, The Cochrane database of systematic reviews.

[19]  J. Hell,et al.  Biochemical properties and subcellular distribution of an N-type calcium hannel α1 subunit , 1992, Neuron.

[20]  B Malgrange,et al.  The anti‐epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA‐ and glycine‐gated currents , 2002, British journal of pharmacology.

[21]  Y. Smith,et al.  Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet , 2006, Annals of neurology.

[22]  F. H. Lopes da Silva,et al.  Development of tolerance to levetiracetam in rats with chronic epilepsy , 2008, Epilepsia.

[23]  C. Faingold,et al.  Pontine reticular formation neurons are implicated in the neuronal network for generalized clonic seizures which is intensified by audiogenic kindling , 2005, Brain Research.

[24]  W. Löscher,et al.  The antiepileptic drug levetiracetam selectively modifies kindling‐induced alterations in gene expression in the temporal lobe of rats , 2004, European Journal of Neuroscience.

[25]  O. Lindvall,et al.  Evidence for long-term reduction of noradrenaline release after kindling in the rat hippocampus , 1990, Brain Research.

[26]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[27]  G. Tunnicliff,et al.  Basis of the antiseizure action of phenytoin. , 1996, General pharmacology.

[28]  W. Löscher,et al.  Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions. , 2002, European journal of pharmacology.

[29]  V. Shkryl,et al.  Selective Blockade of N‐Type Calcium Channels by Levetiracetam , 2002, Epilepsia.

[30]  Kevin G Becker,et al.  Identification and analysis of plasticity-induced late-response genes , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Shannon,et al.  Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats , 2007, Epilepsy & Behavior.

[32]  R. Racine,et al.  Effects of midbrain raphe lesions or systemic p-chlorophenylalanine on the development of kindled seizures in rats , 1979, Brain Research Bulletin.

[33]  F. Sjöqvist,et al.  Measurement of diphenylhydantoin in 0.1-ml plasma samples: gas chromatography and radioimmunoassay compared. , 1976, Clinical chemistry.

[34]  J. Schellens,et al.  Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients. , 2006, Basic & clinical pharmacology & toxicology.

[35]  J. McNamara,et al.  A Point Mutation (D79N) of the α2A Adrenergic Receptor Abolishes the Antiepileptogenic Action of Endogenous Norepinephrine , 1998, The Journal of Neuroscience.

[36]  T. Tomson,et al.  Therapeutic Drug Monitoring of the Newer Antiepileptic Drugs , 2003, Therapeutic drug monitoring.

[37]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Kristi L. Budzinski,et al.  Large structural change in isolated synaptic vesicles upon loading with neurotransmitter. , 2009, Biophysical journal.

[39]  P. Rutecki,et al.  Altered hippocampal network excitability in the hypernoradrenergic mutant mousetottering , 1990, Brain Research.

[40]  P. Patsalos,et al.  A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb LO59) in serum or plasma by high performance liquid chromatography. , 1996, Therapeutic drug monitoring.

[41]  R. Kuzniecky,et al.  Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. , 2003, Archives of neurology.